Fresenius Medical Care AG KGaA EBITDA 2012-2026 | FMS
Fresenius Medical Care AG KGaA annual and quarterly EBITDA history from 2012 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Fresenius Medical Care AG KGaA EBITDA for the quarter ending June 30, 2026 was $0.960B, a 2.05% increase year-over-year.
- Fresenius Medical Care AG KGaA EBITDA for the twelve months ending June 30, 2026 was $3.896B, a 14.45% increase year-over-year.
- Fresenius Medical Care AG KGaA 2025 annual EBITDA was $3.765B, a 10.99% increase from 2024.
- Fresenius Medical Care AG KGaA 2024 annual EBITDA was $3.392B, a 0.41% increase from 2023.
- Fresenius Medical Care AG KGaA 2023 annual EBITDA was $3.378B, a 4.29% decline from 2022.
|
Fresenius Medical Care AG KGaA Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $3,765 |
| 2024 | $3,392 |
| 2023 | $3,378 |
| 2022 | $3,530 |
| 2021 | $4,112 |
| 2020 | $4,672 |
| 2019 | $4,326 |
| 2018 | $4,444 |
| 2017 | $3,502 |
| 2016 | $3,413 |
| 2015 | $3,044 |
| 2014 | $2,954 |
| 2013 | $2,878 |
| 2012 | $2,768 |
| 2011 | $2,601 |
|
Fresenius Medical Care AG KGaA Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-06-30 | $960 |
| 2026-03-31 | $877 |
| 2025-12-31 | $1,059 |
| 2025-09-30 | $1,001 |
| 2025-06-30 | $941 |
| 2025-03-31 | $765 |
| 2024-12-31 | $767 |
| 2024-09-30 | $931 |
| 2024-06-30 | $870 |
| 2024-03-31 | $823 |
| 2023-12-31 | $913 |
| 2023-09-30 | $845 |
| 2023-06-30 | $870 |
| 2023-03-31 | $750 |
| 2022-12-31 | $949 |
| 2022-09-30 | $933 |
| 2022-06-30 | $788 |
| 2022-03-31 | $860 |
| 2021-12-31 | $1,035 |
| 2021-09-30 | $1,050 |
| 2021-06-30 | $987 |
| 2021-03-31 | $1,040 |
| 2020-12-31 | $1,192 |
| 2020-09-30 | $1,253 |
| 2020-06-30 | $1,173 |
| 2020-03-31 | $1,054 |
| 2019-12-31 | $1,180 |
| 2019-09-30 | $1,108 |
| 2019-06-30 | $1,017 |
| 2019-03-31 | $1,021 |
| 2018-12-31 | $929 |
| 2018-09-30 | $810 |
| 2018-06-30 | $1,880 |
| 2018-03-31 | $826 |
| 2017-12-31 | $800 |
| 2017-09-30 | $952 |
| 2017-06-30 | $853 |
| 2017-03-31 | $896 |
| 2016-12-31 | $990 |
| 2016-09-30 | $867 |
| 2016-06-30 | $835 |
| 2016-03-31 | $722 |
| 2015-12-31 | $843 |
| 2015-09-30 | $793 |
| 2015-06-30 | $728 |
| 2015-03-31 | $680 |
| 2014-12-31 | $849 |
| 2014-09-30 | $767 |
| 2014-06-30 | $725 |
| 2014-03-31 | $612 |
| 2013-12-31 | $828 |
| 2013-09-30 | $716 |
| 2013-06-30 | $691 |
| 2013-03-31 | $644 |
| 2012-12-31 | $711 |
| 2012-09-30 | $714 |
| 2012-06-30 | $711 |
| 2012-03-31 | $632 |
| 2011-12-31 | $721 |
| 2011-09-30 | $669 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.924B | $22.202B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $240.872B | 27.34 |
| Intuitive Surgical (ISRG) | United States | $138.955B | 47.11 |
| Edwards Lifesciences (EW) | United States | $50.820B | 31.41 |
| IQVIA Holdings (IQV) | United States | $43.853B | 23.45 |
| Waters (WAT) | United States | $41.424B | 30.82 |
| IDEXX Laboratories (IDXX) | United States | $40.308B | 35.98 |
| DexCom (DXCM) | United States | $33.717B | 35.04 |
| Alcon (ALC) | Switzerland | $32.170B | 19.95 |
| Mettler-Toledo (MTD) | United States | $27.898B | 31.02 |
| STERIS (STE) | Ireland | $19.991B | 19.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.827B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.536B | 17.43 |
| Penumbra (PEN) | United States | $12.510B | 82.49 |
| Globus Medical (GMED) | United States | $9.946B | 15.06 |
| Glaukos (GKOS) | United States | $9.662B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.434B | 28.12 |
| Teleflex (TFX) | United States | $5.276B | 14.23 |
| LivaNova (LIVN) | United Kingdom | $4.298B | 21.73 |
| Integer Holdings (ITGR) | United States | $4.293B | 19.89 |
| Pulse Biosciences (PLSE) | United States | $3.814B | 0.00 |
| Veracyte (VCYT) | United States | $3.199B | 26.18 |
| TransMedics (TMDX) | United States | $2.987B | 43.87 |
| AxoGen (AXGN) | United States | $2.378B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.143B | 27.05 |
| Elekta AB (EKTAY) | Sweden | $1.906B | 17.83 |
| Nihon Kohden (NHNKY) | Japan | $1.687B | 15.45 |
| Alphatec Holdings (ATEC) | United States | $1.572B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.377B | 0.00 |
| OPKO Health (OPK) | United States | $1.246B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.184B | 6.16 |
| Tandem Diabetes Care (TNDM) | United States | $1.174B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Artivion (AORT) | United States | $1.138B | 43.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.105B | 0.00 |
| IRadimed (IRMD) | United States | $1.050B | 45.88 |
| Beta Bionics (BBNX) | United States | $0.985B | 0.00 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.795B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.708B | 17.05 |
| AngioDynamics (ANGO) | United States | $0.638B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.570B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.559B | 1611.00 |
| Tactile Systems Technology (TCMD) | United States | $0.503B | 20.56 |
| NeuroPace (NPCE) | United States | $0.490B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.442B | 0.00 |
| 908 Devices (MASS) | United States | $0.435B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.426B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.422B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.355B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.292B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.242B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| RxSight (RXST) | United States | $0.216B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.160B | 0.00 |
| FocalTherics (FOCL) | France | $0.156B | 0.00 |
| Inogen (INGN) | United States | $0.136B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.081B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.076B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 24.09 |
| DarioHealth (DRIO) | United States | $0.071B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vaso (VASO) | United States | $0.052B | 29.49 |
| Sensus Healthcare (SRTS) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| InspireMD (NSPR) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| PAVmed (PAVM) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.028B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.011B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |